Heart Attack News and Research

RSS

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Alexion Pharmaceuticals, Inc. announced today that the company has submitted marketing applications to the U.S. Food and Drug Administration and the European Medicines Agency for Soliris as a treatment for patients with atypical Hemolytic Uremic Syndrome.

7 Apr 2011

Patients with type 2 diabetes can benefit from metformin than other drugs

New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin.

7 Apr 2011

Cliffside encourages patients to continue antidepressant use despite health risks

Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of heart attack or stroke in middle-age men taking the medications.

7 Apr 2011

Parents and schools may contribute to childhood obesity

Two of the biggest influences on children — parents and schools — may unintentionally contribute to childhood obesity. That's the observation of Susan Terwilliger, clinical associate professor in the Decker School of Nursing at Binghamton University, who studies the problem.

7 Apr 2011

Scientists identify cellular switch that may help treat cardiovascular disease, cancer

Scientists at the University of Hull have identified a cellular 'on-off' switch that may have implications for treating cardiovascular disease and cancer.

7 Apr 2011

Estrogen therapy for menopause, study looks at risks-benefits

...

6 Apr 2011

Device to treat resistant hypertension lowers blood pressure by 33 points

A device designed to treat people with resistant hypertension helped lower blood pressure by 33 points, a substantial drop that would otherwise require patients to take an additional three or four drugs, on top of this subgroup's usual regimen of up to five drugs, to control their difficult-to-treat condition.

6 Apr 2011

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

5 Apr 2011

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

A new risk calculator can predict the risk of postoperative complications occurring for individual bariatric surgery patients, according to a study published in the March issue of the Journal of the American College of Surgeons. The risk calculator will help in surgical decision-making and will help patients better understand what they can expect during recovery in order to prepare for a bariatric operation.

5 Apr 2011

The New England Journal of Medicine publishes positive results from NorthShore's EVEREST II trial

NorthShore University HealthSystem interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial, that were concurrently published in The New England Journal of Medicine.

5 Apr 2011

Guilt may play as motivational tool for cardiovascular patients

Current research supports the notion that lifestyle choices influence cardiovascular health, but to what extent specific emotions play is undefined. Now, new research from the University of Pennsylvania School of Medicine has revealed the role that guilt may play as a motivational tool for cardiovascular patients.

5 Apr 2011

$Ranolazine is an effective treatment for patients with refractory angina$

Ranolazine is an effective treatment for patients with refractory angina

Ranolazine is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.

5 Apr 2011

Both radial and femoral approaches are safe and effective for angioplasty

In the future you may hear the doctor say: "Give me your arm and I'll do some heart surgery."

5 Apr 2011

Implementation of STEMI guidelines, protocols in hospitals without cardiac catheterization labs improves dramatically

The implementation of acute heart attack or ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing orders in Minnesota community hospitals without cardiac catheterization labs has dramatically improved since 2003, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.

5 Apr 2011

MIEMSS designates Sinai Hospital as Cardiac Interventional Center

The Maryland Institute for Emergency Medical Services Systems (MIEMSS) designated Sinai Hospital of Baltimore as a Cardiac Interventional Center on April 1, 2011.

5 Apr 2011

Exercise may decrease blood flow and oxygen in hypertensive people

UT Southwestern Medical Center researchers have identified one reason people with hypertension experience an even greater increase in their blood pressure when they exercise, and they've learned how to prevent the rise.

5 Apr 2011

Long hours at work damages heart: Study

According to British scientists, people who regularly work long hours may be significantly increasing their risk of developing heart disease that could eventually kill them.

5 Apr 2011

Medical industry veteran set to play key role as Microvisk gears up to launch Smartstrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, today announced that it has strengthened its Board with the appointment of medical industry veteran, Bill Moffitt, as Chairman and Peter Whitehouse as CFO.

4 Apr 2011

Study reveals increased incidence of major adverse cardiac events in patients with severe psoriasis

Psoriasis is a common inflammatory skin disease, and if severe, has been demonstrated to be a risk factor for cardiovascular (CV) disease. However, the degree to which psoriasis is associated with major adverse cardiac events (MACE), such as heart attack, stroke, and cardiovascular death has not been defined. Now, new research from the University of Pennsylvania School of Medicine has revealed an increased incidence of MACE in patients with severe psoriasis.

4 Apr 2011

Abbott's XIENCE V Coronary Stent System data presented at ACC meeting

A pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented today further reinforces the positive clinical performance of Abbott's market-leading XIENCE V Everolimus Eluting Coronary Stent System.

4 Apr 2011

Heart Attack News and Research

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Patients with type 2 diabetes can benefit from metformin than other drugs

Cliffside encourages patients to continue antidepressant use despite health risks

Parents and schools may contribute to childhood obesity

Scientists identify cellular switch that may help treat cardiovascular disease, cancer

Estrogen therapy for menopause, study looks at risks-benefits

Device to treat resistant hypertension lowers blood pressure by 33 points

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

The New England Journal of Medicine publishes positive results from NorthShore's EVEREST II trial

Guilt may play as motivational tool for cardiovascular patients

Ranolazine is an effective treatment for patients with refractory angina

Both radial and femoral approaches are safe and effective for angioplasty

Implementation of STEMI guidelines, protocols in hospitals without cardiac catheterization labs improves dramatically

MIEMSS designates Sinai Hospital as Cardiac Interventional Center

Exercise may decrease blood flow and oxygen in hypertensive people

Long hours at work damages heart: Study

Medical industry veteran set to play key role as Microvisk gears up to launch Smartstrip®

Study reveals increased incidence of major adverse cardiac events in patients with severe psoriasis

Abbott's XIENCE V Coronary Stent System data presented at ACC meeting

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News